AU6586298A - Glucagon-like peptide-1 analogs - Google Patents

Glucagon-like peptide-1 analogs

Info

Publication number: AU6586298A
Authority: AU; Australia
Prior art keywords: glucagon; analogs; peptide
Prior art date: 1997-03-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU65862/98A

Inventor

James A Hoffmann

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-31

Filing date

1998-03-25

Publication date

1998-10-22

1998-03-25 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

1998-10-22 Publication of AU6586298A publication Critical patent/AU6586298A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU65862/98A 1997-03-31 1998-03-25 Glucagon-like peptide-1 analogs Abandoned AU6586298A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US4116797P	1997-03-31	1997-03-31
US60041167		1997-03-31
PCT/US1998/005945 WO1998043658A1 (en)	1997-03-31	1998-03-25	Glucagon-like peptide-1 analogs

Publications (1)

Publication Number	Publication Date
AU6586298A true AU6586298A (en)	1998-10-22

Family

ID=21915105

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU65862/98A Abandoned AU6586298A (en)	1997-03-31	1998-03-25	Glucagon-like peptide-1 analogs

Country Status (2)

Country	Link
AU (1)	AU6586298A (en)
WO (1)	WO1998043658A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2777283B1 (en) *	1998-04-10	2000-11-24	Adir	NOVEL GLUCAGON-PEPTIDE- 1 (7-37) ANALOGUE PEPTIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US7259136B2 (en)	1999-04-30	2007-08-21	Amylin Pharmaceuticals, Inc.	Compositions and methods for treating peripheral vascular disease
US6284725B1 (en)	1998-10-08	2001-09-04	Bionebraska, Inc.	Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
US6429197B1 (en) *	1998-10-08	2002-08-06	Bionebraska, Inc.	Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain
PL393611A1 (en) *	1998-12-07	2011-05-09	Societe De Conseils De Recherches Et D'applications Scientifiques Sas	Compounds being GLP-1 analogues, compositions containing such compounds and the use of such compounds
WO2000069911A1 (en)	1999-05-17	2000-11-23	Conjuchem, Inc.	Long lasting insulinotropic peptides
US6514500B1 (en)	1999-10-15	2003-02-04	Conjuchem, Inc.	Long lasting synthetic glucagon like peptide {GLP-!}
ES2253353T3 (en)	2000-03-08	2006-06-01	Novo Nordisk A/S	SERICO CHOLESTEROL REDUCTION.
JP4881533B2 (en)	2000-05-19	2012-02-22	アミリン・ファーマシューティカルズ，インコーポレイテッド	Treatment of acute coronary arteriovenous syndrome with GLP-1
CA2430934C (en)	2000-12-01	2011-06-21	Takeda Chemical Industries, Ltd.	A method of producing sustained-release preparations of a bioactive substance using high-pressure gas
SI1687019T1 (en)	2003-11-20	2018-04-30	Novo Nordisk A/S	PROPILED GLIKO-CONTAINING PEPTIDAL FORMULATIONS OPTIMAL FOR MANUFACTURING AND FOR USE IN INJECTION DEVICES
EP1694356B1 (en)	2003-12-09	2011-02-16	Novo Nordisk A/S	Regulation of food preference using glp-1 agonists
US7538185B2 (en)	2004-01-08	2009-05-26	Theratechnologies Inc.	Glucagon-like peptide-1 analogs with long duration of action
EP1758575A1 (en)	2004-06-11	2007-03-07	Novo Nordisk A/S	Counteracting drug-induced obesity using glp-1 agonists
EP1845105A4 (en)	2005-01-14	2009-02-18	Wuxi Grandchamp Pharmaceutical	Modified exendins and uses thereof
RU2417078C2 (en)	2005-05-10	2011-04-27	Лабораториз Фурнье С.А.	New application of liver x receptor agonists
ES2495741T3 (en)	2006-04-20	2014-09-17	Amgen, Inc	GLP-1 Compounds
WO2008019147A2 (en)	2006-08-04	2008-02-14	Amylin Pharmaceuticals, Inc.	Use of exendins, exendin agonists and glp-1 receptor agonists for altering the concentration of fibrinogen
WO2011123943A1 (en)	2010-04-09	2011-10-13	Mount Sinai Hospital	Methods for treating disorders of the gastrointestinal tract using a glp-1 agonist
WO2014010586A1 (en)	2012-07-10	2014-01-16	武田薬品工業株式会社	Pharmaceutical preparation for injection
CN118903386A (en)	2017-08-24	2024-11-08	诺和诺德股份有限公司	GLP-1 compositions and uses thereof
BR112022013746A2 (en)	2020-02-18	2022-10-11	Novo Nordisk As	CAGRILINTIDE AQUEOUS FORMULATION, SEMAGLUTIDE AQUEOUS FORMULATION, MEDICAL DEVICE, AND, FIXED DOSE COMBINATION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5705483A (en) *	1993-12-09	1998-01-06	Eli Lilly And Company	Glucagon-like insulinotropic peptides, compositions and methods
EP0879279A4 (en) *	1996-02-06	2000-07-12	Lilly Co Eli	Diabetes therapy

1998
- 1998-03-25 AU AU65862/98A patent/AU6586298A/en not_active Abandoned
- 1998-03-25 WO PCT/US1998/005945 patent/WO1998043658A1/en active Search and Examination

Also Published As

Publication number	Publication date
WO1998043658A1 (en)	1998-10-08

Publication	Publication Date	Title
IL136377A0 (en)	2001-06-14	Glucagon-like peptide-1 crystals
AU6586298A (en)	1998-10-22	Glucagon-like peptide-1 analogs
AU1617399A (en)	1999-06-28	Glp-1 formulations
HUP9903714A3 (en)	2000-07-28	Glp-1 derivatives
AU2610599A (en)	1999-09-15	N-terminally truncated glp-1 derivatives
ZA981343B (en)	1998-11-16	Sulfonylurea-glitazone combinations for diabetes
AU2524995A (en)	1995-11-29	Neurokinine (tachykinine) antagonists
AU9501798A (en)	1999-04-12	Low work-function electrode
AU9036098A (en)	1999-03-16	Parallel mechanism
AU1274099A (en)	1999-05-10	Low work-function electrode
AU9552498A (en)	1999-05-24	Phthalocyanine analogs
AU5335798A (en)	1999-05-10	Stomatic composition
AU8747498A (en)	1999-03-16	Food-preservative composition
AU9066598A (en)	1999-03-01	Substituted 4-benzoyl-pyrazoles
AU8917398A (en)	1999-05-10	Torch
AU5203698A (en)	1998-08-06	Fluid-treatment assemblies
EP0903415A3 (en)	2003-01-29	Structure expansée
AU2394697A (en)	1997-11-12	Porcine retrovirus
AU8121998A (en)	1999-01-25	Composition
AU5953598A (en)	1998-10-01	Plaque-inhibiting composites
ZA984895B (en)	1999-04-20	Solvent replacement
AU8072498A (en)	1999-01-04	Heregulin-like factor
AU1098499A (en)	1999-05-10	Emulsifier-lipid composition
AU6090898A (en)	1998-07-31	Substituted 4-benzoyl-pyrazoles
ZA977791B (en)	1998-03-02	GLP-1 derivatives.